Project Summary
The goal of this study (K01 DA048174; NIDA) is to understand the role of injection partnership-level factors on HCV risk and measure preferences for SSP among YWID in rural Appalachian Ohio. Dr. Lancaster will leverage the NIDA-funded National Rural Opioid Initiative (UG3) study infrastructure and community-academic partnerships to specifically:
- Describe the contribution of injection partnership-level factors on HCV risk behaviors among YWID in rural Appalachia
- Determine the effect of injection partnership-level factors on HCV risk behaviors among YWID in rural Appalachia
- Elicit preferences for SSP among YWID in rural Appalachia.